LONA
LeonaBio, Inc.
NASDAQ: LONA · HEALTHCARE · BIOTECHNOLOGY
$7.04
+1.00% today
Updated 2026-07-29
Market cap
$69.14M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-24.09
Dividend yield
—
52W range
$3 – $14
Volume
0.0M
WallStSmart proprietary scores
29
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.5
Quality
B3.0
Profitability
D5.0
Valuation
C+2/9
Piotroski F-Score
Weak
-8.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$18.00
+155.68%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.01x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -8.19 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-20.90M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-95.64M | $-117.67M | $-96.94M | $-105.61M | $-32.95M |
| EPS | — | — | — | — | $-24.09 |
| Free cash flow | $-73.61M | $-101.06M | $-97.20M | $-45.73M | $-20.90M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
LeonaBio, Inc. trades at $7.04. Our Smart Value Score of 29/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -8.19, it sits in the distress.
Frequently asked questions
What is LeonaBio, Inc.'s stock price?
LeonaBio, Inc. (LONA) trades at $7.04.
Is LeonaBio, Inc. overvalued?
LeonaBio, Inc. carries a Smart Value Score of 29/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of LeonaBio, Inc. (LONA)?
The 12-month analyst consensus target is $18.00, about 155.7% above the current $7.04. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
LeonaBio, Inc.'s Altman Z-Score is -8.19, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-298.80%
Beta2.02
50D MA$8.89
200D MA$6.96
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—